Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells (original) (raw)
References
Pietersen AM, van Lohuizen M . Stem cell regulation by polycomb repressors: postponing commitment. Curr Opin Cell Biol 2008; 20: 201–207. ArticleCASPubMed Google Scholar
Lessard J, Sauvageau G . Bmi-1 determines proliferative capacity of normal and leukemic stem cells. Nature 2003; 423: 255–260. ArticleCASPubMed Google Scholar
Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302–305. ArticleCASPubMed Google Scholar
Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product, Bmi-1. Immunity 2004; 21: 843–851. ArticleCASPubMed Google Scholar
Jacobs JJL, Kieboom K, Marino S, DePinho RA, van Lohuizen M . The oncogene and Polycomb-group gene bmi1 regulates proliferation and senescence through the ink4a locus. Nature 1999; 397: 164–168. ArticleCASPubMed Google Scholar
Oguro H, Iwama A, Morita Y, Kamijo T, van Lohuizen M, Nakauchi H . Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J Exp Med 2006; 203: 2247–2253. ArticleCASPubMedPubMed Central Google Scholar
Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006; 125: 301–313. ArticleCASPubMedPubMed Central Google Scholar
Oguro H, Yuan J, Ichikawa H, Ikawa T, Yamazaki S, Kawamoto H et al. Poised lineage specification in multipotent hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell 2010; 6: 279–286. ArticleCASPubMed Google Scholar
Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H et al. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. Blood 2006; 107: 305–308. ArticleCASPubMed Google Scholar
Mohty M, Yong AS, Szydlo RM, Apperley JF, Melo JV . The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood 2007; 110: 380–383. ArticleCASPubMed Google Scholar
Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y, Kimura A . Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia 2007; 21: 1116–1122. ArticleCASPubMed Google Scholar
Cozzio A, Passegu E, Ayton PM, Karsunky H, Cleary ML, Weissman IL . Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003; 17: 3029–3035. ArticleCASPubMedPubMed Central Google Scholar
Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004; 6: 587–596. ArticleCASPubMed Google Scholar
Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006; 442: 818–822. ArticleCASPubMed Google Scholar
Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008; 13: 69–80. ArticleCASPubMedPubMed Central Google Scholar
Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39: 232–236. ArticleCASPubMed Google Scholar
Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003; 31: 1007–1014. ArticleCASPubMed Google Scholar
Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z et al. The Wnt/β-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010; 327: 1650–1652. ArticleCASPubMedPubMed Central Google Scholar
Singh MK, Petry M, Haenig B, Lescher B, Leitges M, Kispert A . The T-box transcription factor Tbx15 is required for skeletal development. Mech Dev 2005; 122: 131–144. ArticleCASPubMed Google Scholar
Chiba T, Miyagi S, Saraya A, Aoki R, Seki A, Morita Y et al. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res 2008; 68: 7742–7749. ArticleCASPubMed Google Scholar
Rizo A, Olthof S, Han L, Vellenga E, de Haan G, Schuringa JJ . Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis. Blood 2009; 114: 1498–1505. ArticleCASPubMed Google Scholar
Bracken AP, Helin K . Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 2009; 9: 773–784. ArticleCASPubMed Google Scholar
Ortega S, Malumbres M, Barbacid M . Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochimica et Biophysica Acta 2002; 1602: 73–87. CASPubMed Google Scholar
Bruggeman SW, Hulsman D, Tanger E, Buckle T, Blom M, Zevenhoven J et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 2007; 12: 328–341. ArticleCASPubMed Google Scholar
Wiederschain D, Chen L, Johnson B, Bettano K, Jackson D, Taraszka J et al. Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. Mol Cell Biol 2007; 27: 4968–4979. ArticleCASPubMedPubMed Central Google Scholar
Douglas D, Hsu JH, Hung L, Cooper A, Abdueva D, van Doorninck J et al. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression. Cancer Res 2008; 68: 6507–6515. ArticleCASPubMedPubMed Central Google Scholar